
John C. Fox
Examiner (ID: 3915)
| Most Active Art Unit | 3753 |
| Art Unit(s) | 3407, 3753, 2899, 2602, 3727 |
| Total Applications | 3766 |
| Issued Applications | 2890 |
| Pending Applications | 143 |
| Abandoned Applications | 734 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17342118
[patent_doc_number] => 20220008449
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-13
[patent_title] => A METHOD OF MIMICKING BENEFITS OF DIETARY RESTRICTION BY TRANSIENTLY UPREGULATING ER STRESS RESPONSE
[patent_app_type] => utility
[patent_app_number] => 17/294082
[patent_app_country] => US
[patent_app_date] => 2019-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9217
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17294082
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/294082 | A METHOD OF MIMICKING BENEFITS OF DIETARY RESTRICTION BY TRANSIENTLY UPREGULATING ER STRESS RESPONSE | Dec 12, 2019 | Abandoned |
Array
(
[id] => 17480727
[patent_doc_number] => 20220088231
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => RADIOIMMUNOCONJUGATES AND DNA DAMAGE AND REPAIR INHIBITOR COMBINATION THERAPY
[patent_app_type] => utility
[patent_app_number] => 16/619433
[patent_app_country] => US
[patent_app_date] => 2019-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17931
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16619433
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/619433 | RADIOIMMUNOCONJUGATES AND DNA DAMAGE AND REPAIR INHIBITOR COMBINATION THERAPY | Dec 2, 2019 | Pending |
Array
(
[id] => 17503422
[patent_doc_number] => 20220096524
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-31
[patent_title] => METHODS OF PROMOTING HEALTHY CATCH-UP GROWTH
[patent_app_type] => utility
[patent_app_number] => 17/298194
[patent_app_country] => US
[patent_app_date] => 2019-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9182
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17298194
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/298194 | METHODS OF PROMOTING HEALTHY CATCH-UP GROWTH | Nov 26, 2019 | Abandoned |
Array
(
[id] => 16267290
[patent_doc_number] => 20200268777
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-27
[patent_title] => PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/695324
[patent_app_country] => US
[patent_app_date] => 2019-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16618
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16695324
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/695324 | PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF | Nov 25, 2019 | Abandoned |
Array
(
[id] => 18272450
[patent_doc_number] => 20230093692
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => C10-Alkylene Substituted 13-Membered Macrolides and Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 17/294878
[patent_app_country] => US
[patent_app_date] => 2019-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 62019
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17294878
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/294878 | C10-alkylene substituted 13-membered macrolides and uses thereof | Nov 17, 2019 | Issued |
Array
(
[id] => 17368378
[patent_doc_number] => 20220023430
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => GLYCOPOLYSIALYLATION OF BLINATUMOMAB
[patent_app_type] => utility
[patent_app_number] => 17/292911
[patent_app_country] => US
[patent_app_date] => 2019-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15163
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17292911
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/292911 | GLYCOPOLYSIALYLATION OF BLINATUMOMAB | Nov 12, 2019 | Abandoned |
Array
(
[id] => 16555861
[patent_doc_number] => 20210001009
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-07
[patent_title] => BIOGUM AND BOTANICAL GUM HYDROGEL BIOINKS FOR THE PHYSIOLOGICAL 3D BIOPRINTING OF TISSUE CONSTRUCTS FOR IN VITRO CULTURE AND TRANSPLANTATION
[patent_app_type] => utility
[patent_app_number] => 16/979452
[patent_app_country] => US
[patent_app_date] => 2019-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7502
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16979452
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/979452 | BIOGUM AND BOTANICAL GUM HYDROGEL BIOINKS FOR THE PHYSIOLOGICAL 3D BIOPRINTING OF TISSUE CONSTRUCTS FOR IN VITRO CULTURE AND TRANSPLANTATION | Oct 24, 2019 | Abandoned |
Array
(
[id] => 15800267
[patent_doc_number] => 20200123276
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-23
[patent_title] => CROSS-LINKED HA BEADS AND PROCESS FOR MAKING SAME
[patent_app_type] => utility
[patent_app_number] => 16/661683
[patent_app_country] => US
[patent_app_date] => 2019-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2291
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16661683
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/661683 | CROSS-LINKED HA BEADS AND PROCESS FOR MAKING SAME | Oct 22, 2019 | Abandoned |
Array
(
[id] => 15493115
[patent_doc_number] => 20200046746
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-13
[patent_title] => ANTI-AGING COMPOSITIONS AND METHODS FOR USING SAME
[patent_app_type] => utility
[patent_app_number] => 16/656437
[patent_app_country] => US
[patent_app_date] => 2019-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18209
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16656437
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/656437 | ANTI-AGING COMPOSITIONS AND METHODS FOR USING SAME | Oct 16, 2019 | Abandoned |
| 16/592151 | TINTED FILLER AND METHOD | Oct 2, 2019 | Abandoned |
Array
(
[id] => 15405357
[patent_doc_number] => 20200023000
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-23
[patent_title] => SYNERGISM OF GOS AND POLYFRUCTOSE
[patent_app_type] => utility
[patent_app_number] => 16/586544
[patent_app_country] => US
[patent_app_date] => 2019-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12669
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16586544
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/586544 | SYNERGISM OF GOS AND POLYFRUCTOSE | Sep 26, 2019 | Abandoned |
Array
(
[id] => 15360851
[patent_doc_number] => 20200016190
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-16
[patent_title] => SUBLINGUAL ADMINISTRATION OF VITAMIN B12 DISPERSED IN A HYDROPHOBIC CONTINUOUS PHASE
[patent_app_type] => utility
[patent_app_number] => 16/583574
[patent_app_country] => US
[patent_app_date] => 2019-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1758
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16583574
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/583574 | SUBLINGUAL ADMINISTRATION OF VITAMIN B12 DISPERSED IN A HYDROPHOBIC CONTINUOUS PHASE | Sep 25, 2019 | Abandoned |
Array
(
[id] => 15342581
[patent_doc_number] => 20200009182
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-09
[patent_title] => METHODS AND COMPOSITIONS FOR DISRUPTING BIOFILM UTILIZING CHITOSAN-DERIVATIVE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/572053
[patent_app_country] => US
[patent_app_date] => 2019-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48156
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16572053
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/572053 | Methods and compositions for disrupting biofilm utilizing chitosan-derivative compounds | Sep 15, 2019 | Issued |
Array
(
[id] => 16735631
[patent_doc_number] => 10961267
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-30
[patent_title] => Prodrugs of a JAK inhibitor compound for treatment of gastrointestinal inflammatory disease
[patent_app_type] => utility
[patent_app_number] => 16/555222
[patent_app_country] => US
[patent_app_date] => 2019-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 14713
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16555222
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/555222 | Prodrugs of a JAK inhibitor compound for treatment of gastrointestinal inflammatory disease | Aug 28, 2019 | Issued |
Array
(
[id] => 16893181
[patent_doc_number] => 11034714
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-15
[patent_title] => Process of making regadenoson and novel polymorphs thereof
[patent_app_type] => utility
[patent_app_number] => 16/553372
[patent_app_country] => US
[patent_app_date] => 2019-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3015
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16553372
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/553372 | Process of making regadenoson and novel polymorphs thereof | Aug 27, 2019 | Issued |
Array
(
[id] => 16877981
[patent_doc_number] => 11028114
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-08
[patent_title] => Amphotericin B derivatives with improved therapeutic index
[patent_app_type] => utility
[patent_app_number] => 16/530109
[patent_app_country] => US
[patent_app_date] => 2019-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 46
[patent_no_of_words] => 16414
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16530109
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/530109 | Amphotericin B derivatives with improved therapeutic index | Aug 1, 2019 | Issued |
Array
(
[id] => 17393410
[patent_doc_number] => 11242412
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-08
[patent_title] => Method for the qualification of preparations of pentosan polysulfate, raw materials and production processes thereof
[patent_app_type] => utility
[patent_app_number] => 16/526336
[patent_app_country] => US
[patent_app_date] => 2019-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5365
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16526336
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/526336 | Method for the qualification of preparations of pentosan polysulfate, raw materials and production processes thereof | Jul 29, 2019 | Issued |
Array
(
[id] => 17052110
[patent_doc_number] => 20210261544
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-26
[patent_title] => FGFR INHIBITOR, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/253113
[patent_app_country] => US
[patent_app_date] => 2019-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13952
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 1231
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17253113
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/253113 | FGFR inhibitor, preparation method therefor and application thereof | Jul 22, 2019 | Issued |
Array
(
[id] => 17200187
[patent_doc_number] => 20210340282
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-04
[patent_title] => PARAMYLON-BASED RESIN, MOLDING MATERIAL, MOLDED BODY, AND METHOD FOR PRODUCING PARAMYLON-BASED RESIN
[patent_app_type] => utility
[patent_app_number] => 17/258955
[patent_app_country] => US
[patent_app_date] => 2019-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14219
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17258955
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/258955 | PARAMYLON-BASED RESIN, MOLDING MATERIAL, MOLDED BODY, AND METHOD FOR PRODUCING PARAMYLON-BASED RESIN | Jul 9, 2019 | Abandoned |
Array
(
[id] => 15960445
[patent_doc_number] => 20200163974
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-28
[patent_title] => USE OF GABAA RECEPTOR ANTAGONISTS FOR THE TREATMENT OF EXCESSIVE SLEEPINESS AND DISORDERS ASSOCIATED WITH EXCESSIVE SLEEPINESS
[patent_app_type] => utility
[patent_app_number] => 16/460226
[patent_app_country] => US
[patent_app_date] => 2019-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14068
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16460226
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/460226 | USE OF GABAA RECEPTOR ANTAGONISTS FOR THE TREATMENT OF EXCESSIVE SLEEPINESS AND DISORDERS ASSOCIATED WITH EXCESSIVE SLEEPINESS | Jul 1, 2019 | Abandoned |